Early mortality risk stratification after SARS-CoV-2 infection

por Lundon, D.J., Kelly, B.D., Nair, S., Bolton, D.M., Kyprianou, N., Wiklund, P., Tewari, A.
Publicado 2021

Early mortality risk stratification after SARS-CoV-2 infection

por Lundon, D.J., Kelly, B.D., Nair, S., Bolton, D.M., Kyprianou, N., Wiklund, P., Tewari, A.
Publicado 2021

Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsy

por Wei, G., Kelly, B. D., Timm, B., Perera, M., Lundon, D. J., Jack, G., Bolton, D. M.
Publicado 2021

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation

por Lundon, D. J., Boland, A., Prencipe, M., Hurley, G., O’Neill, A, Kay, E., Aherne, S. T., Doolan, P., Madden, S. F., Clynes, M., Morrissey, C., Fitzpatrick, J. M., Watson, R. W.
Publicado 2017

Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease

por Archer, M., Dogra, N., Dovey, Z., Ganta, T., Jang, H.-S., Khusid, J. A., Lantz, A., Mihalopoulos, M., Stockert, J. A., Zahalka, A., Björnebo, L., Gaglani, S., Noh, M. R., Kaplan, S. A., Mehrazin, R., Badani, K. K., Wiklund, P., Tsao, K., Lundon, D. J., Mohamed, N., Lucien, F., Padanilam, B., Gupta, M., Tewari, A. K., Kyprianou, N.
Publicado 2021